Lewy body dementia: genes and variants
Explore variant evidence for Lewy body dementia across 3 analyzed proteins (GBA1, SNCA, APOE). Linked ClinVar records include 8 pathogenic or likely pathogenic variants, 6 variants of uncertain significance and 3 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Lewy body dementia
GBA1: Lysosomal acid glucosylceramidase
It degrades glucosylceramide within lysosomes and is essential for normal sphingolipid turnover. Biallelic pathogenic variants cause Gaucher disease, while heterozygous pathogenic variants are among the strongest genetic risk factors for Parkinson disease.
6 ClinVar pathogenic / likely pathogenic and 7 uncertain variants in GBA1 have source records linked to Lewy body dementia. Association strength is not clinical gene validity.
SNCA: Alpha-synuclein
Alpha-synuclein is a neuronal protein that supports synaptic-vesicle trafficking, priming, and neurotransmitter release. Misfolded or aggregated alpha-synuclein is a defining feature of Parkinson disease and Lewy-body disorders.
2 ClinVar pathogenic / likely pathogenic and 2 uncertain variants in SNCA have source records linked to Lewy body dementia. Association strength is not clinical gene validity.
APOE: Apolipoprotein E
It redistributes cholesterol and other lipids between tissues by directing remnant lipoproteins to LDL-receptor-family members. The common epsilon4 isoform strongly increases late-onset Alzheimer disease risk and also influences plasma lipids and cardiovascular risk.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in APOE have source records linked to Lewy body dementia. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): VCP.
ClinVar pathogenic and likely pathogenic variants linked to Lewy body dementia
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| GBA1 G416S | 416 | Pathogenic / likely pathogenic (★★) | |
| GBA1 W351S | 351 | Pathogenic / likely pathogenic (★★) | |
| GBA1 V433L | 433 | Pathogenic / likely pathogenic (★★) | |
| GBA1 T362I | 362 | Pathogenic / likely pathogenic (★★) | |
| GBA1 N409S | 409 | Pathogenic / likely pathogenic (★★) | |
| SNCA A53T | 53 | 3 | Pathogenic / likely pathogenic (★★) |
| SNCA E46K | 46 | 3 | Pathogenic / likely pathogenic (★) |
| GBA1 P454L | 454 | Pathogenic / likely pathogenic |
Which prediction tools work for Lewy body dementia
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CATVariant: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 85 out of 100
- ESM1b (LLR): 85 out of 100
- PolyPhen-2: 76 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 73 out of 100
Same protein, different disease
- Gaucher disease also has ClinVar records linked to GBA1 variants; they fall mostly in different places as the Lewy body dementia variants (132 pathogenic / likely pathogenic).
- Parkinson disease also has ClinVar records linked to GBA1 variants; they fall mostly in different places as the Lewy body dementia variants (8 pathogenic / likely pathogenic).
- Gaucher disease perinatal lethal also has ClinVar records linked to GBA1 variants; they fall mostly in different places as the Lewy body dementia variants (5 pathogenic / likely pathogenic).
- Gaucher disease - ophthalmoplegia - cardiovascular calcification also has ClinVar records linked to GBA1 variants; they fall mostly in different places as the Lewy body dementia variants (3 pathogenic / likely pathogenic).
Diseases related to Lewy body dementia
- Parkinson disease, also linked to GBA1 and SNCA
- Familial hypercholesterolemia, also linked to APOE
- Gaucher disease, also linked to GBA1
- Alzheimer disease, also linked to APOE
- Type 2 diabetes mellitus, also linked to APOE
- Hyperlipoproteinemia, also linked to APOE
- Age related macular degeneration, also linked to APOE
- Diabetes mellitus, also linked to APOE
- Autosomal dominant Parkinson disease, also linked to SNCA
- Familial type 3 hyperlipoproteinemia, also linked to APOE
- Young-onset Parkinson disease, also linked to SNCA
- Gaucher disease perinatal lethal, also linked to GBA1
Frequently asked questions
Which genes have records linked to Lewy body dementia?
This view contains 3 analyzed proteins: GBA1, SNCA, APOE. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 8 pathogenic or likely pathogenic variants, 6 variants of uncertain significance and 3 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 18 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center